Boehringer Ingelheim accused of misusing US patents to delay asthma-drug rivals Ruchika Sharma7 March 2024 12:38 PM ISTGerman drugmaker Boehringer Ingelheim was accused in a federal lawsuit in Boston on Wednesday of improperly submitting patents to the U.S. Food and...
Gilead Sciences, Merus collaborate to discover novel antibody-based trispecific T-cell engagers Ruchika Sharma7 March 2024 11:59 AM ISTFoster City: Gilead Sciences, Inc. and Merus N.V. have announced a research collaboration, option and license agreement to discover novel dual...
Roche Pharma India forays into Ophthalmology space with launch of Vabysmo Ruchika Sharma6 March 2024 4:10 PM ISTAs the world's first bispecific antibody, Vabysmo is a single molecule designed to target and inhibit the effects of two targets, providing the...
EMA validates marketing authorisation applications for AstraZeneca, Daiichi Sankyo datopotamab deruxtecan in lung, breast cancer Ruchika Sharma6 March 2024 3:25 PM ISTCambridge: The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for AstraZeneca and Daiichi Sankyo’s...
Bayer to hold off on plans to break apart group for up to 3 years Ruchika Sharma6 March 2024 1:30 PM ISTFrankfurt: Bayer will hold off on plans to break apart the group for up to three years so that the new CEO can focus on problems including debt...
WHO warns of growing resistance to GSK HIV drug Ruchika Sharma6 March 2024 12:30 PM ISTThe World Health Organization (WHO) has said resistance to GSK's HIV drug dolutegravir has exceeded levels observed during its trials, citing...
USFDA successfully closes inspection at Torrent Pharma Gujarat facility Ruchika Sharma6 March 2024 11:57 AM ISTAhmedabad: Torrent Pharma has announced that the US Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (“EIR”)...
Strides Pharma Science arm secures USFDA nod for Gabapentin tablets for neuropathic pain treatment Ruchika Sharma5 March 2024 4:11 PM ISTGabapentin is an anticonvulsant medication primarily used to treat partial seizures and neuropathic pain.
Cadila Pharma unveils quadrivalent influenza vaccine Cadiflu Tetra Ruchika Sharma5 March 2024 3:30 PM ISTNew Delhi: Cadila Pharmaceuticals has said it has launched a vaccine to prevent influenza, a recurrent and widespread viral...
No custom duty on medicines for rare diseases: Delhi HC IANS5 March 2024 12:55 PM ISTThe court has directed customs authorities to prioritise and expedite the clearance of such medical imports, ensuring that treatments reach patients...
Cipla gets CDSCO nod to market novel antibiotic Plazomicin in India, to launch under brand name Zemdri Ruchika Sharma5 March 2024 12:11 PM ISTMumbai: Cipla Limited has received approval from the Central Drugs Standard Control Organization (CDSCO) to market the novel antibiotic...
Sandoz concludes acquisition of Cimerli business from Coherus BioSciences Ruchika Sharma5 March 2024 10:30 AM ISTCIMERLI is indicated for the treatment of certain retinal diseases that, if left untreated, can cause vision loss, which ranks among the top 10 causes...
